Table I.
Statistical differences of clinicopathological characteristics between patients with DM (n=28) and without DM (n=82).
| Variables | DM, n (%) | Non-DM, n (%) | P-value |
|---|---|---|---|
| Sex (male) | 13 (46.4) | 49 (59.8) | 0.220 |
| Age (≥45 years) | 14 (50.0) | 49 (59.8) | 0.368 |
| TNM stage (I–II) | 5 (17.9) | 21 (25.6) | 0.404 |
| Tumor diameter (>5 cm) | 19 (67.9) | 51 (62.2) | 0.591 |
| R0 | 17 (60.7) | 47 (57.3) | 0.753 |
| Differentiation | 0.263 | ||
| Low | 1 (3.6) | 12 (14.6) | |
| Moderate | 23 (82.1) | 62 (75.6) | |
| High | 4 (14.3) | 8 (9.8) | |
| Lymph node metastasis | 10 (35.7) | 25 (30.5) | 0.608 |
| Intrahepatic metastasis | 8 (28.6) | 15 (18.3) | 0.248 |
| Multiplicity | 14 (50.0) | 30 (36.6) | 0.211 |
| Vascular invasion | 13 (46.4) | 19 (23.2) | 0.019a |
| Alanine aminotransferase (>100 IU/l) | 2 (7.1) | 15 (18.3) | 0.229 |
| Aspartate aminotransferase (>100 IU/l) | 5 (17.9) | 18 (22.0) | 0.646 |
| Total bilirubin (>34 µmol/l) | 4 (14.3) | 20 (24.4) | 0.264 |
| Albumin (>35 g/dl) | 23 (82.1) | 72 (87.8) | 0.451 |
| Prothrombin time (>14 sec) | 2 (7.1) | 3 (3.7) | 0.600 |
a
P<0.05. DM, diabetes mellitus; IU, international unit.